Meridian Bioscience (VIVO) and "Directive" by Robert Frost
Meridian Bioscience (VIVO) is a favorite blog subject of mine. I discuss VIVO and also read a poem by Robert Frost, "Directive".
This stock is a favorite of mine producing disease test kits and has a record of steady revenue, earnings, and free cash flow growth. They pay a solid and growing dividend and have a strong financial balance sheet.